Common Contracts
3 similar Option Purchase Agreement contracts by Nuvasive Inc
OPTION PURCHASE AGREEMENT among NUVASIVE, INC., PROGENTIX ORTHOBIOLOGY, B.V. and The Sellers listed on Schedule A attached hereto January 13, 2009Option Purchase Agreement • May 26th, 2010 • Nuvasive Inc • Surgical & medical instruments & apparatus • New York
THIS OPTION PURCHASE AGREEMENT (“Agreement”) is made as of January 13, 2009 (“Effective Date”), by and among NuVasive, Inc., a Delaware corporation (“Purchaser”), Progentix Orthobiology B.V., a company organized under the laws of the Netherlands (the “Acquired Company”), the shareholders of the Acquired Company as set forth on Schedule A attached hereto (each a “Seller,” and collectively, the “Sellers,” and along with the Acquired Company, the “Seller Parties”) and Edward van Wezel and Joost D de Bruijn (each, the “Sellers’ Representative”).
OPTION PURCHASE AGREEMENT among NUVASIVE, INC., PROGENTIX ORTHOBIOLOGY, B.V. and The Sellers listed on Schedule A attached hereto January 13, 2009Option Purchase Agreement • February 26th, 2010 • Nuvasive Inc • Surgical & medical instruments & apparatus • New York
THIS OPTION PURCHASE AGREEMENT (“Agreement”) is made as of January 13, 2009 (“Effective Date”), by and among NuVasive, Inc., a Delaware corporation (“Purchaser”), Progentix Orthobiology B.V., a company organized under the laws of the Netherlands (the “Acquired Company”), the shareholders of the Acquired Company as set forth on Schedule A attached hereto (each a “Seller,” and collectively, the “Sellers,” and along with the Acquired Company, the “Seller Parties”) and Edward van Wezel and Joost D de Bruijn (each, the “Sellers’ Representative”).
OPTION PURCHASE AGREEMENT among NUVASIVE, INC., PROGENTIX ORTHOBIOLOGY, B.V. and The Sellers listed on Schedule A attached hereto January 13, 2009Option Purchase Agreement • May 8th, 2009 • Nuvasive Inc • Surgical & medical instruments & apparatus • New York
THIS OPTION PURCHASE AGREEMENT (“Agreement”) is made as of January 13, 2009 (“Effective Date”), by and among NuVasive, Inc., a Delaware corporation (“Purchaser”), Progentix Orthobiology B.V., a company organized under the laws of the Netherlands (the “Acquired Company”), the shareholders of the Acquired Company as set forth on Schedule A attached hereto (each a “Seller,” and collectively, the “Sellers,” and along with the Acquired Company, the “Seller Parties”) and Edward van Wezel and Joost D de Bruijn (each, the “Sellers’ Representative”).
